This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

12 Jul 2013

FDA approves Decitabine for Injection

Dr Reddy’s Laboratories has launched a generic version of its branded Dacogen (Decitabine for Injection) drug.


The Food and Drug Administration (FDA) has granted approval to Dr Reddy’s Laboratories' Decitabine for Injection (50mg), and the manufacturer has launched it on the US marketplace.

Related News